INS and Insulin resistance: A decrease in insulin-induced molecular signaling, termed insulin resistance (IR), is a major pathogenic mechanism in MetS and T2DM, and may contribute to the associated cognitive impairments (Biessels and Reagan, 2015; Kim and Feldman, 2015).